Abstract:Functional peptides that are made up of diverse endogenous amino acids with a specific sequence and length have shown various functionalities including specific biological recognition and cell penetrating ability for biomedical applications. Therefore, incorporation of peptide with a certain tailor-made amino acid sequence to the delivery systems has endowed the resulting delivery vehicles with specific functions, which provided a robust strategy for enhancing the therapeutic efficiency for malignant diseases. To make a timely review on this hot subject of research, we summarized the recent progress on peptide-functionalized delivery vehicles for enhanced cancer therapy with an emphasis on the chemistry adopted for the conjugation of peptide compared to most of the published reviews with a focus on the property and performance of the peptide-functionalized delivery systems. The primary synthetic strategies used for peptide conjugation were first summarized. An exhibition of four different types of peptide-functionalized delivery vehicles were next presented following a classification standard of the functions of each peptide category including tumor-targeting peptide, cell-penetrating peptide, subcellular organelle-targeting peptide and tumor-penetrating peptide. A concluding remark on the future direction of this rapidly developing research field was made finally. The important principles on the design of peptide, screening of the conjugation strategy, and optimization of peptide property that were drawn from the detailed comparison of the representative literature in this review will provide useful guidelines for the future development of advanced peptide-functionalized delivery platforms with enhanced therapeutic efficiency for cancer therapy.

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic

Peptide-Drug Conjugate: A Novel Drug Design Approach

Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).

Peptide-Drug Conjugates: A New Hope for Cancer Management

Peptide Drug Conjugates and Their Role in Cancer Therapy

Advancements in peptide-based therapeutics: Design, synthesis and clinical applications

Source and exploration of the peptides used to construct peptide-drug conjugates

Peptide-drug conjugates: A new paradigm for targeted cancer therapy

Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy

Peptide-Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics

'Renovation of old drugs' - can peptide drug conjugates lead the post-ADC era?

Recent Advances and Computational Approaches in Peptide Drug Discovery

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Polypeptides–Drug Conjugates for Anticancer Therapy

Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems

Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

Review on therapeutic potential of peptides: Advancements in synthesis methods, linear and cyclic peptides, and strategies for overcoming challenges

The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations

Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency

Peptide-functionalized delivery vehicles for enhanced cancer therapy